About Crl Diagnostics Private Limited
Data last updated: 24 December 2025
Crl Diagnostics Private Limited is a private limited company based in New Delhi, Delhi, India. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 26 September 2011, the company has been in operation for over 15 years.
Registered with ROC Delhi under CIN U93000DL2011PTC225518.
Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. Formerly known as Zenex Labs Private Limited. It is led by directors including Ravi Tomar and Nirankar Nath Bali.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 10 First Second And Third Floor Avtar Enclave Rohtak Road, New Delhi, Delhi, India – 110063.
As per the financials filed for FY 2025, the company reported a revenue of ₹101.01 Cr, a growth of 31% compared to the previous year.
The company has a workforce of approximately 221 employees as per the latest available data.
The company is associated with 1 brand - Crl Diagnostics. As per MCA filings, the company has open charges of ₹1.59 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website crldiagnostics.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address10 First Second And Third Floor Avtar Enclave Rohtak Road, New Delhi, Delhi, India – 110063
-
IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Crl Diagnostics Private Limited
Crl Diagnostics Private Limited operates one associated brand: CRL Diagnostics. These brands represent Crl Diagnostics Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Offers laboratory testing, health packages, and COVID-19 services in India. | crldiagnostics.com |
Competitors & Alternatives of Crl Diagnostics Private Limited
Brands and companies operating in the same space as Crl Diagnostics Private Limited include Dr Lal PathLabs, Redcliffe Labs, Metropolis India and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Dr Lal PathLabs
|
Chain of pathology and radiology labs | Gurugram, India, India | 1949 |
Redcliffe Labs
|
Home-based diagnostic tests are booked via an online platform. | Noida, India, India | 2018 |
Metropolis India
|
Diagnostic centers are operated as a nationwide chain. | Mumbai, India, India | 1981 |
Orange health
|
At-home diagnostic tests are booked and collected by phlebotomists. | Bengaluru, India, India | 2020 |
Agilus Diagnostics
|
Leading diagnostic chain providing quality blood test and full body checkup services | Gurugram, India, India | 1995 |
Apollo Diagnostics
|
Provides pathology lab tests, health check packages, and home sample collection. | Hyderabad, India, India | 2015 |
Sterling Accuris Diagnostics
|
Pathology diagnostic services are offered via a chain of labs. | Ahmedabad, India, India | 2015 |
Airmed
|
Provider of a chain of diagnostic labs | Ahmedabad, India, India | 2016 |
Business Activity of Crl Diagnostics Private Limited
Crl Diagnostics Private Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | ********* |
Auditor Details of Crl Diagnostics Private Limited
Crl Diagnostics Private Limited is audited by VARUN JOHRY & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VARUN JOHRY & ASSOCIATES | blur-value | blur-value | blur-value |
Board of Directors of Crl Diagnostics Private Limited
Crl Diagnostics Private Limited is currently managed by 5 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Ravi Tomar
Also directs:
House Of Smiles Private Limited
|
Director | 15 Oct 2012 | 13 Years 8 Months | Current |
| Nirankar Nath Bali | Director | 27 Jan 2016 | 10 Years 5 Months | Current |
| Manoj Kumar Pathak | Director | 27 Jan 2016 | 10 Years 5 Months | Current |
| Kamal Taya | Director | 27 Jan 2016 | 10 Years 5 Months | Current |
|
Chandra Shekhar Tripathi
Also directs:
Shivah Infraventure Llp
|
Director | 27 Jan 2016 | 10 Years 5 Months | Current |
Financials of Crl Diagnostics Private Limited FY 2024 filings available
Crl Diagnostics Private Limited reported revenue of ₹101.01 Cr (up 31% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Crl Diagnostics Private Limited
As of FY 2023, Crl Diagnostics Private Limited's shareholding pattern shows 65.00% by promoters, 35.00% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Crl Diagnostics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Nov 2024 | Hdfc Bank Limited | ₹14.9 Lakh | Open |
| 28 Oct 2024 | Hdfc Bank Limited | ₹12.05 Lakh | Open |
| 14 Oct 2024 | Hdfc Bank Limited | ₹51.94 Lakh | Open |
| 14 Mar 2022 | Others | ₹22.89 Lakh | Open |
| 10 Mar 2022 | Others | ₹13.79 Lakh | Open |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Crl Diagnostics Private Limited
Crl Diagnostics Private Limited has a workforce of 221 employees as of Apr 06, 2024.
Employee Count & EPFO Data of Crl Diagnostics Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Crl Diagnostics Private Limited
GSTIN & GST Filing Data of Crl Diagnostics Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Crl Diagnostics Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Crl Diagnostics Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Crl Diagnostics Private Limited
MSME Payment Delays by Crl Diagnostics Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Crl Diagnostics Private Limited
Subsidiaries & Group Companies of Crl Diagnostics Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Crl Diagnostics Private Limited with ownership details.
MCA Filings & Documents of Crl Diagnostics Private Limited
MCA Filings & Documents of Crl Diagnostics Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Crl Diagnostics Private Limited
Frequently Asked Questions about Crl Diagnostics Private Limited
Crl Diagnostics Private Limited is an active private limited company in the healthcare sector based in New Delhi, Delhi, India. It was incorporated on 26 September 2011 (15+ years old) and is registered under CIN U93000DL2011PTC225518. The company has 221 employees.
Crl Diagnostics Private Limited reported revenue of ₹101.01 Cr for FY 2025 (up 31.00% YoY).
The current directors of Crl Diagnostics Private Limited are:
The primary industry of Crl Diagnostics Private Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.
Crl Diagnostics Private Limited can be reached at the registered office: 10 First Second And Third Floor Avtar Enclave Rohtak Road, New Delhi, Delhi, India – 110063, or through the website crldiagnostics.com.
The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.